Join the 'Postoperative Ocular Inflammation' group to help and get support from people like you. How it works
Postoperative Ocular Inflammation Blog
| Tweet |
ISTA Pharmaceuticals Receives FDA Approval for Bromday
Posted 20 Oct 2010 by Drugs.com
IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ – ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for Bromday (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. ISTA expects to launch Bromday (formerly referred to as XiDay) prior to the end of 2010. "Bromday is the only once-daily ophthalmic nonsteroidal anti-inflammatory drug (NSAID) for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. We believe the convenience of a once-daily eye drop will help with treatment compliance and benefit patients recovering from cataract surgery," stated Vicente Anido, Jr., ... Read more
Related support groups: Postoperative Ocular Inflammation, Bromfenac Ophthalmic
Ask a Question
Further Information
Related Condition Support Groups
Related Drug Support Groups
Pred Forte, Nevanac, Lotemax, Omnipred, Durezol, Acular, Bromday, Econopred Plus, Alrex, view more... Econopred, loteprednol, Xibrom, difluprednate, nepafenac, Acuvail, Acular LS, Pred Mild, rimexolone, Ocu-Pred-A, AK-Pred, Inflamase Forte, medrysone, Ocu-Pred Forte, Ocu-Pred, Acular PF, Voltaren Ophthalmic, Vexol, Prednisol, Inflamase Mild, Ocufen